Executive Secretary

VIII Symposium "Design, Obtaining and Development of Drugs" "SICF"

VIII International Symposium on Chemistry and Pharmaceutical Sciences

SICF

VIII Symposium "Design, Obtaining and Development of Drugs"

mutante de interleucina-2 (il-2) × pegylation ×

Book your talks

Plan your experience by adding your favorites talks to your wishlist

Tuesday 14
November 2023

PEGylation strategy for improving the antitumoral activity of the IL-2 mutant no alpha.
Marianniz Díaz Hernández

actividad antitumoral antitumor activity interleucina 2 (il-2) interleukin 2 (il-2) pegilación pegylation polietilenglicol (peg) polyethylene glycol (peg)

PEGylation strategy for improving the pharmacokinetic activity of the IL-2 no-alpha mutein.
Marianniz Díaz Hernández

actividad antitumoral. antitumor activity. farmacocinética interleukin-2 (il-2) mutant mutante de interleucina-2 (il-2) pegilación pegylation pharmacokinetic

Instituto Finlay de Vaunas

EAA Heriberto Duquesne

Gold

Álamo Empresa Cárnica

Silver

BIOCUBAFARMA

Centro de Análisis del Ciclo de Vida (CADIS)